GIST and follicular lymphoma in a rare association – unusual intestinal occlusion case-report

Authors

  • José Pinto Hospital de Braga http://orcid.org/0000-0003-1890-4035
  • Ana Ribeiro Hospital de Braga
  • Teresa Carneiro Hospital de Braga
  • Dina Luis Hospital de Braga
  • António Gomes Hospital de Braga

Keywords:

Follicular lymphoma, gastrointestinal stromal tumours, GIST, sub-occlusion

Abstract

GISTs are stromal tumors considered to be sporadic. However, more and more studies describe association between these cancer and other tumors. The association of GIST to lymphomas is particularly rare because the molecular pathway in their development has nothing in common. The authors review the issue and report a case of GIST and follicular-lymphoma association based from a clinical history of a man, 79 years old, subjected to laparotomy in March 2013 because of an intra-abdominal mass of unknown etiology that was causing sub-occlusion, with ongoing worsening pain and abdominal discomfort. The histology of the resected tumor mass documented the presence of an association of a high-risk GIST with a follicular lymphoma. GISTs are rare and have sporadic associations to other cancers. This poorly understood connection can hide diagnostic surprises, you should never forget when we address this type of tumor. Therefore GIST’s patients are the clear example that all patients should be well studied preoperatively and followed cautiously postoperatively.

Downloads

Download data is not yet available.

Author Biographies

José Pinto, Hospital de Braga

Interno de Cirurgia Geral, Hospital de Braga

Ana Ribeiro, Hospital de Braga

Assistente de Cirurgia Geral

Teresa Carneiro, Hospital de Braga

Assistente de Cirurgia Geral

Dina Luis, Hospital de Braga

Assistente Graduada de Cirurgia Geral

António Gomes, Hospital de Braga

Chefe de Serviço de Cirurgia Geral

References

Mazzola P, Spitale A, Banfi S, et al. Epidemiology and molecular biology of gastrointestinal stromal tumors (GISTs): a population-based study in the South of Switzerland, 1999–2005. Histol Histopathol.2008;23:1379–86.

DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg. 2000;231:51–58.

Pandurengan RK, Dumont AG, Araujo DM, et al. Survival of patients with multiple primary malignancies: a study of 783 patients with gastrointestinal stromal tumor. Ann Oncol. 2010;21:2107–11.

Hechtman JF, DeMatteo R, Nafa K, et al. Additional Primary Malignancies in Patients with Gastrointestinal Stromal Tumor (GIST): A Clinicopathologic Study of 260 Patients with Molecular Analysis and Review of the Literature. Ann Surg Oncol. 2015; 22(8):2633-9

Murphy JD, Ma GL, Baumgartner JM, et al. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study. Cancer. 2015;121(17):2960-7

Karanikas M, Machairiotis N, Zarogoulidis P, et al. Non-Hodgkin lymphoma and GIST: molecular pathways and clinical expressions. Onco Targets Ther. 2012; 5:433-8

Zinner MJ, Ashley SW, Maingot’s abdominal operations – 11th ed, pp 621-622

National Comprehensive Cancer Network, Soft Tissue Sarcoma – v2.2106

Published

2018-09-09

Issue

Section

Clinical Case

Most read articles by the same author(s)